No Data
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
Cann Group to Raise Nearly AU$712,000 via Private Placement; Shares Hit All-Time Low
Cann Group Ltd. Expands Market Presence With New Securities Issuance
Cann Group Ltd Reports Strategic Shift and Financial Improvements for Half-Year 2024
Cann Group Agrees to Drawdown on Convertible Loan Facility
Cann Group Ltd: Cann FY25 Half Year Results
